ASPIRA (ASPIRA) Fair Value & Analysis

IN · Market cap ₹1.3B

A ASPIRA ASPIRA · BSE

Price₹128.90

Fair Value₹144.70

Upside+12.3%

Quality71/100

Watch ASPIRA for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range ₹100.91 – ₹188.50

Fair value as of: Jul 5, 2026

From 21 valuation models · updated today

Share price +2.7% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹51.52 – ₹133.29 · fair‑value band ₹100.91 – ₹188.50 · the ₹128.90 price screens below the ₹144.70 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ASPIRA (ASPIRA) currently trades at ₹128.90, while our model-based Fair Value estimate is ₹144.70 — implying the stock looks roughly 12.3% undervalued today. We read business quality at 71/100 (solid quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, ASPIRA generated revenue of ₹250M at a net margin of 0.2%. Revenue grew 12.9% year over year. It earns a return on equity of 0.4%. Fundamentals as of Jul 5, 2026

Key figures & financial health

Revenue (TTM) ₹250M

Revenue growth (YoY) +12.9%

Net margin 0.2%

Return on equity 0.4%

Free cash flow ₹7.6M FY2025

P/E ratio 2,578.0

More key figures

Operating margin -11.2%

EPS (TTM) ₹0.0500

EPS growth (YoY) +85.4%

Net debt ₹872K FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

ASPIRA reported revenue of ₹250M in FY2025 versus ₹195M in FY2021, a compound +6.3%/yr. Reported net income was ₹513K in FY2025, compounding −67.3%/yr from FY2021.

Revenue +6.3%/yr

FY21 ₹195M

FY22 ₹145M

FY23 ₹132M

FY24 ₹220M

FY25 ₹250M

Net income −67.3%/yr

FY21 ₹44.6M

FY22 −₹887K

FY23 −₹26.7M

FY24 ₹20.2M

FY25 ₹513K

Is ASPIRA fairly valued? → Check now

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is ASPIRA (ASPIRA) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹144.70 versus a price of ₹128.90 — about +12% (undervalued). Model-based estimate, not financial advice.

What is the fair value of ASPIRA?

Our model-based fair value for ASPIRA is ₹144.70 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹128.90.

What is the quality score of ASPIRA?

ASPIRA has a Quality Score of 71/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of ASPIRA (ASPIRA)?

ASPIRA reported trailing-twelve-month revenue of about ₹250M (latest available figure, as of Jul 5, 2026).

What is the net profit margin of ASPIRA?

The net profit margin of ASPIRA is about 0.2%, meaning it keeps roughly 0.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.